Rating History for Ovid Therapeutics Inc (OVID) by Cantor Fitzgerald
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/9/2026 | Imogen Mansfield | New Coverage | Overweight (N/A) |
N/A (N/A) |
2.34 (2.15) |
-8.12% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||



